SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at The Thomas Weisel Partners 2008 Healthcare Conference on Thursday, September 4, 2008, at 2:40 p.m. Eastern Time at the Four Seasons Boston Hotel.
